Abstract

Acute ketamine administration evokes rapid and sustained antidepressant effects in treatment-resistant patients. However, ketamine also produces transient perceptual disturbances similarly to those evoked by other non-competitive NMDA-R antagonists like phencyclidine (PCP). Although the brain networks involved in both ketamine actions are not fully understood, PCP and ketamine activate thalamo-cortical networks after NMDA-R blockade in GABAergic neurons of the reticular thalamic nucleus (RtN). Given the involvement of thalamo-cortical networks in processing sensory information, these networks may underlie psychotomimetic action. Since the GluN2C subunit is densely expressed in the thalamus, including the RtN, we examined the dependence of psychotomimetic and antidepressant-like actions of ketamine on the presence of GluN2C subunits, using wild-type and GluN2C knockout (GluN2CKO) mice. Likewise, since few studies have investigated ketamine’s effects in females, we used mice of both sexes. GluN2C deletion dramatically reduced stereotyped (circling) behavior induced by ketamine in male and female mice, while the antidepressant-like effect was fully preserved in both genotypes and sexes. Despite ketamine appeared to induce similar effects in both sexes, some neurobiological differences were observed between male and female mice regarding c-fos expression in thalamic nuclei and cerebellum, and glutamate surge in prefrontal cortex. In conclusion, the GluN2C subunit may discriminate between antidepressant-like and psychotomimetic actions of ketamine. Further, the abundant presence of GluN2C subunits in the cerebellum and the improved motor coordination of GluN2CKO mice after ketamine treatment suggest the involvement of cerebellar NMDA-Rs in some behavioral actions of ketamine.

Highlights

  • Major depressive disorder (MDD) is predicted to be the second leading cause of illness-induced disability by 20301, causing a very large socioeconomic burden[2,3]

  • Shows that N-methyl-D-aspartate receptor (NMDA-R) containing the GluN2C subunit are involved in the motor components of the psychotomimetic effects induced by ketamine but not in its antidepressant-like action

  • Prevention of ketamine’s effects on GluN2C subunits or the design of new agents lacking affinity for this subunit may be a step toward preventing some of the undesirable side effects of ketamine, while keeping the antidepressant response

Read more

Summary

Introduction

Major depressive disorder (MDD) is predicted to be the second leading cause of illness-induced disability by 20301, causing a very large socioeconomic burden[2,3]. The World Health Organization[4] estimates to affect 322 million people, a 4.4% worldwide point prevalence, being more common among females (5.1%) than males (3.6%). This high prevalence, together with the slow onset of Tarrés-Gatius et al Translational Psychiatry (2020)10:427 psychotic-dissociative-state[11,12]. There is an urgent need to understand the basis of the psychotomimetic and antidepressant effects of ketamine in order to develop new fast-acting antidepressants devoid of pro-psychotic actions and abuse potential

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call